Grimes & Company Inc. reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 17.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,589 shares of the healthcare conglomerate’s stock after selling 4,658 shares during the quarter. Grimes & Company Inc.’s holdings in UnitedHealth Group were worth $13,207,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC increased its stake in UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Swedbank AB acquired a new position in UnitedHealth Group in the 1st quarter worth approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in UnitedHealth Group by 107.8% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after purchasing an additional 1,196,758 shares during the period. Lone Pine Capital LLC acquired a new position in UnitedHealth Group during the second quarter valued at $480,903,000. Finally, Dimensional Fund Advisors LP grew its stake in UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after acquiring an additional 880,183 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Trading Down 0.7 %
Shares of UNH opened at $560.82 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The firm has a market capitalization of $517.87 billion, a price-to-earnings ratio of 36.54, a P/E/G ratio of 1.67 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock’s 50-day moving average price is $584.16 and its 200 day moving average price is $536.49.
UnitedHealth Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.50%. UnitedHealth Group’s payout ratio is 54.72%.
Analyst Ratings Changes
Several analysts recently commented on UNH shares. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. TD Cowen boosted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Cantor Fitzgerald lifted their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Argus raised their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Finally, Barclays lowered their price target on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research note on Tuesday. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $615.53.
Check Out Our Latest Report on UnitedHealth Group
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- What Are the U.K. Market Holidays? How to Invest and Trade
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- The Significance of Brokerage Rankings in Stock Selection
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- What Are Dividend Champions? How to Invest in the Champions
- Tesla Stock: Buy the Dips, Sell the Rips
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.